本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NovoCure Limited

17.50
+0.05930.34%
成交量:4.82萬
成交額:84.57萬
市值:19.51億
市盈率:-11.57
高:17.69
開:17.52
低:17.42
收:17.44
資料載入中...
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/12/02

重要事件披露

Form 8-K - Current report
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/03

重要事件披露

Form 8-K - Current report
2024/07/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]